Share

Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type calcium channels.

Carly A Buckner, Alison L Buckner, Stan A Koren, Michael A Persinger, Robert M Lafrenie

PAPERpubmedPloS one2015Animal studyEffect: benefitEvidence: Low

Abstract

Electromagnetic field (EMF) exposures affect many biological systems. The reproducibility of these effects is related to the intensity, duration, frequency, and pattern of the EMF. We have shown that exposure to a specific time-varying EMF can inhibit the growth of malignant cells. Thomas-EMF is a low-intensity, frequency-modulated (25-6 Hz) EMF pattern. Daily, 1 h, exposures to Thomas-EMF inhibited the growth of malignant cell lines including B16-BL6, MDA-MB-231, MCF-7, and HeLa cells but did not affect the growth of non-malignant cells. Thomas-EMF also inhibited B16-BL6 cell proliferation in vivo. B16-BL6 cells implanted in syngeneic C57b mice and exposed daily to Thomas-EMF produced smaller tumours than in sham-treated controls. In vitro studies showed that exposure of malignant cells to Thomas-EMF for > 15 min promoted Ca(2+) influx which could be blocked by inhibitors of voltage-gated T-type Ca(2+) channels. Blocking Ca(2+) uptake also blocked Thomas-EMF-dependent inhibition of cell proliferation. Exposure to Thomas-EMF delayed cell cycle progression and altered cyclin expression consistent with the decrease in cell proliferation. Non-malignant cells did not show any EMF-dependent changes in Ca(2+) influx or cell growth. These data confirm that exposure to a specific EMF pattern can affect cellular processes and that exposure to Thomas-EMF may provide a potential anti-cancer therapy.

AI evidence extraction

At a glance
Study type
Animal study
Effect direction
benefit
Population
Cancer cell lines (B16-BL6, MDA-MB-231, MCF-7, HeLa) and non-malignant cells; syngeneic C57b mice implanted with B16-BL6 cells
Sample size
—
Exposure
ELF other · Daily 1 h exposures; in vitro >15 min for Ca2+ influx effects
Evidence strength
Low
Confidence: 74% · Peer-reviewed: yes

Main findings

A low-intensity, frequency-modulated time-varying EMF pattern (Thomas-EMF; 25–6 Hz) inhibited growth of multiple malignant cell lines with daily 1 h exposures, while not affecting non-malignant cell growth. In syngeneic C57b mice implanted with B16-BL6 cells, daily Thomas-EMF exposure produced smaller tumours than sham controls. In vitro, >15 min exposure promoted Ca2+ influx that was blocked by T-type Ca2+ channel inhibitors, and blocking Ca2+ uptake also blocked the EMF-dependent inhibition of proliferation; exposure also delayed cell cycle progression and altered cyclin expression.

Outcomes measured

  • Cancer cell growth/proliferation (in vitro)
  • Tumour size/growth (in vivo)
  • Ca2+ influx
  • T-type voltage-gated calcium channel involvement (pharmacologic inhibition)
  • Cell cycle progression
  • Cyclin expression

Limitations

  • Sample size not reported in abstract
  • Exposure intensity not quantified in abstract (only described as low-intensity)
  • Details of sham exposure conditions not provided in abstract
  • In vivo findings limited to one tumour model/cell line (B16-BL6) in mice
View raw extracted JSON
{
  "study_type": "animal",
  "exposure": {
    "band": "ELF",
    "source": "other",
    "frequency_mhz": null,
    "sar_wkg": null,
    "duration": "Daily 1 h exposures; in vitro >15 min for Ca2+ influx effects"
  },
  "population": "Cancer cell lines (B16-BL6, MDA-MB-231, MCF-7, HeLa) and non-malignant cells; syngeneic C57b mice implanted with B16-BL6 cells",
  "sample_size": null,
  "outcomes": [
    "Cancer cell growth/proliferation (in vitro)",
    "Tumour size/growth (in vivo)",
    "Ca2+ influx",
    "T-type voltage-gated calcium channel involvement (pharmacologic inhibition)",
    "Cell cycle progression",
    "Cyclin expression"
  ],
  "main_findings": "A low-intensity, frequency-modulated time-varying EMF pattern (Thomas-EMF; 25–6 Hz) inhibited growth of multiple malignant cell lines with daily 1 h exposures, while not affecting non-malignant cell growth. In syngeneic C57b mice implanted with B16-BL6 cells, daily Thomas-EMF exposure produced smaller tumours than sham controls. In vitro, >15 min exposure promoted Ca2+ influx that was blocked by T-type Ca2+ channel inhibitors, and blocking Ca2+ uptake also blocked the EMF-dependent inhibition of proliferation; exposure also delayed cell cycle progression and altered cyclin expression.",
  "effect_direction": "benefit",
  "limitations": [
    "Sample size not reported in abstract",
    "Exposure intensity not quantified in abstract (only described as low-intensity)",
    "Details of sham exposure conditions not provided in abstract",
    "In vivo findings limited to one tumour model/cell line (B16-BL6) in mice"
  ],
  "evidence_strength": "low",
  "confidence": 0.74,
  "peer_reviewed_likely": "yes",
  "keywords": [
    "time-varying electromagnetic field",
    "Thomas-EMF",
    "ELF",
    "frequency-modulated",
    "25-6 Hz",
    "cancer cell lines",
    "tumour growth",
    "B16-BL6",
    "MDA-MB-231",
    "MCF-7",
    "HeLa",
    "Ca2+ influx",
    "T-type calcium channels",
    "cell cycle",
    "cyclins"
  ],
  "suggested_hubs": []
}

AI can be wrong. Always verify against the paper.

AI-extracted fields are generated from the abstract/metadata and may be incomplete or incorrect. This content is for informational purposes only and is not medical advice.

Comments

Log in to comment.

No comments yet.

NNEMF synthesis

Synthesis pending.

Original record: rfsafe.org paper 4782

Inhibition of cancer cell growth by exposure to a specific time-varying electromagnetic field involves T-type calcium channels. · Non-native EMF